← Back to All Filings

CONMED Officer Files Intent to Sell $150K in Company Stock

Low SignificanceNovember 6, 2025 at 10:02:00 AM EST

CONMED Corp

$CNMD144CIK: 0000816956

Subscribe to track CNMD

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

CONMED Officer Files Intent to Sell $150K in Stock

Company: CONMED Corp (CNMD) Form: 144 | Filed: 2025-11-06 Significance: Low

Insider: Garner Todd W Title: Officer

Transaction (Proposed): • Type: Sale • Shares: 3,500 • Value: $150,500 • Price: ~$43.00/share

Key Insight: This is a low-value, routine sale following the vesting of restricted stock. The transaction represents a negligible percentage of the company's market cap (0.011%) and was filed under a pre-arranged trading plan, indicating it is likely for liquidity or tax purposes rather than a change in outlook.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: CONMED Corp (CNMD)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer at CONMED Corp has filed a notice of proposed sale for 3,500 shares valued at $150,500. The transaction is of low significance, representing a tiny fraction of the company's market capitalization and shares outstanding.
  • Market Impact: Neutral. This small, pre-planned sale following stock vesting is unlikely to influence the market.

Company Information

FieldValue
CompanyCONMED Corp
Ticker SymbolCNMD
CIK0000816956
IndustryElectromedical & Electrotherapeutic Apparatus

Insider Information

FieldValue
NameGarner Todd W
CIK0001726884
Title/PositionOfficer
RelationshipOfficer

Transaction Details

FieldValue
Form Type144 (Notice of Proposed Sale)
Transaction Date2025-11-06 (Approximate)
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved3,500
Price Per Share~$43.00
Total Value$150,500
Shares Owned AfterNot specified
Ownership TypeNot specified

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$150,500
% of Market Cap0.011%
Shares Transacted3,500
% of Shares Outstanding0.011%
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market capitalization of $1.41 billion, this $150,500 transaction is immaterial.
  • Transaction Significance: The sale represents just 0.011% of the market cap and 0.011% of shares outstanding, both well below any threshold for significance. Such transactions are considered routine for executives at public companies.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a notice of a proposed sale, not a completed one. The small size and the fact that the shares were acquired via restricted stock vesting suggest this is a standard 'vest and sell' event for compensation and liquidity purposes. The filing also notes a plan adoption date of August 8, 2025, indicating this is a pre-scheduled trade under a 10b5-1 plan, which further reduces its informational value.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction size is too small to have a noticeable impact on daily trading volume.
  • Sentiment Indicator: Neutral. The market typically disregards small, pre-planned insider sales related to compensation.

Additional Context

Transaction Notes

  • Source of Shares: The filing specifies the shares were acquired on October 31, 2025, through 'Restricted Stock Vesting' as part of compensation.
  • Special Circumstances: The sale is proposed under a trading plan adopted on August 8, 2025, reinforcing its pre-planned nature.
Topics:#SECFiling#InsiderTrading#CNMD#CONMED#Form144#InsiderSell#StockMarket#Investing#FinancialAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.